EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 17-Jun-2026 02:16 ET (17-Jun-2026 06:16 GMT/UTC)

Improved heart and kidney outcomes for type 1 diabetes patients taking GLP-1 weight loss drugs

Johns Hopkins Bloomberg School of Public Health
Peer-Reviewed Publication

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Landmark diabetes trial tests new treatments to bring back ‘hypo’ awareness

University of Leicester
Reports and Proceedings

A trial testing new treatments aimed at restoring warning signs of low blood glucose in people with type 1 diabetes who can no longer perceive when their blood sugars dip dangerously low is underway.

New biomarker in cerebrospinal fluid improves diagnosis of Parkinson's disease and dementia with Lewy bodies

Vrije Universiteit Brussel
Peer-Reviewed Publication

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the scientific journal Nature Medicine, they describe the discovery of a new quantitative biomarker in lumbar fluid (cerebrospinal fluid) that is helping doctors to diagnose Parkinson's disease and Lewy body dementia more accurately.

Journal: Nature Medicine

Excessive screen time signals health risk for young adults

American College of Cardiology
Reports and Proceedings

People who reported spending six or more hours on screens outside of school or work had worse blood pressure, cholesterol and body mass index (BMI) compared with those with more limited screen time, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26).

Meeting: American College of Cardiology's Annual Scientific Session

Transportation noise: An overlooked risk to heart health

American College of Cardiology
Reports and Proceedings

Living in areas with consistently higher levels of noise from transportation was associated with a significantly higher risk of major adverse cardiac events compared with living in quieter areas, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26). Researchers suggest that implementing strategies to reduce exposure to traffic noise from roads, railways and aviation corridors may be a new target for urban planning and improving the heart health of communities.

Meeting: American College of Cardiology's Annual Scientific Session

Fewer seniors with heart disease report skipping meds after Medicare reforms

American College of Cardiology
Peer-Reviewed Publication

Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication non-adherence—skipping or reducing doses, delaying prescription fills or foregoing medications due to cost—after new provisions went into effect limiting out-of-pocket drug costs for Medicare beneficiaries, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26) and simultaneously published in JACC, the flagship journal of the ACC.

Journal: Journal of the American College of Cardiology
Meeting: American College of Cardiology's Annual Scientific Session

When temperatures drop, heart-related deaths rise

American College of Cardiology
Peer-Reviewed Publication

On the heels of one of the coldest winters in memory for large swaths of the country, new research highlights an often overlooked cost of cold weather: months with lower temperatures see significantly greater rates of death from heart attacks, strokes and coronary artery disease than milder months. According to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26), hotter temperatures were also associated with increases in cardiovascular deaths, but at a more modest rate.

Journal: American Journal of Preventive Cardiology
Meeting: American College of Cardiology's Annual Scientific Session

How inflammation drives bone loss in an aggressive childhood leukemia

Tokyo University of Science
Peer-Reviewed Publication

TCF3::HLF-positive B cell acute lymphoblastic leukemia is a rare and highly aggressive childhood cancer that causes severe damage to bones through mechanisms that remain unclear. To tackle this gap, researchers from Japan have developed a new mouse model that closely mirrors the disease as seen in humans. With it, they uncovered an inflammatory feedback loop that accelerates leukemia growth and bone destruction, highlighting a potential therapeutic target to combat disease progression and protect bone health.

Journal: Blood
Funder: Japan Agency for Medical Research and Development, Astellas Foundation for Research on Metabolic Disorders, Uehara Memorial Foundation, Japanese Society of Hematology, NOVARTIS Foundation (Japan) for the Promotion of Science, Princess Takamatsu Cancer Research Fund, Foundation for Promotion of Cancer Research, Cancer Research Institute, Kanazawa University, Japan Science and Technology Agency, JSI Kibou Project

B-type natriuretic peptide as a predictor of kidney disease progression in diabetes

Juntendo University Research Promotion Center
Peer-Reviewed Publication

A new study from Juntendo University suggests that B-type natriuretic peptide (BNP), a biomarker commonly used to detect heart failure, may also help predict chronic kidney disease progression in individuals with diabetes. Researchers found that BNP levels were associated with declining kidney function even within clinically normal ranges. When combined with traditional urinary markers such as urinary albumin-to-creatinine ratio, BNP improved the identification of patients at higher risk of kidney disease progression.

Journal: Diabetes Research and Clinical Practice